Iambic’s IPO, backed by Nvidia, highlights AI’s transformative role in biotech, potentially reshaping drug discovery and investment landscapes.
The post Iambic Therapeutics files for US IPO with Nvidia backing appeared first on Crypto Briefing.
Sep 22, 2026
